science wire

« BACK

Pharmacology



Results 1 - 50 of 3032.
1 2 3 4 5 ... 61 Next »


Health - Pharmacology - 01.12.2022
Large language models help decipher clinical notes
Researchers used a powerful deep-learning model to extract important data from electronic health records that could assist with personalized medicine.

Health - Pharmacology - 30.11.2022
Developing connection standards for heart-on-chips
Heart-on-a-Chip devices are microfluidic devices that enable the replication of a human heart at the microscale.

Health - Pharmacology - 29.11.2022
Multi-million-pound trial will help rapidly find flu treatments this winter
A new national trial, launched today, aims to use pandemic lessons to help quickly find effective treatments for people hospitalised with severe flu.

Health - Pharmacology - 29.11.2022
New tools map seizures in the brain, improve epilepsy treatment
New tools map seizures in the brain, improve epilepsy treatment
Machine learning reveals patterns in brain activity and within minutes can pinpoint where seizures begin Two new models could solve a problem that's long frustrated millions of people with epilepsy and the doctors who treat them: how to find precisely where seizures originate to treat exactly that part of the brain.

Health - Pharmacology - 28.11.2022
Localising BRCA gene mutations to better treat ovarian cancer
Localising BRCA gene mutations to better treat ovarian cancer
An international team highlights the importance of localising BRCA gene mutations for the treatment of ovarian cancer. Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1 in 800 people respectively, significantly increase the risk of certain cancers such as ovarian, breast, pancreatic and prostate cancer.

Health - Pharmacology - 28.11.2022
Blood thinning drug to treat recovery from severe COVID-19 is not effective
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.

Pharmacology - Health - 25.11.2022
Understanding antimicrobial resistance
City of Kitchener's Carl Zehr Square goes blue for World Antimicrobial Awareness Week By Milana Madzarac School of Pharmacy Unnecessary use and misuse of antibiotics and other antimicrobials are increasing the serious problem of antimicrobial resistance.

Health - Pharmacology - 24.11.2022
Beating cancer-related fatigue with personalised interventions
After diagnosis and treatment of breast cancer, many women suffer from cancer-related fatigue. Twenty percent of the patients are still severely fatigued after ten years.

Health - Pharmacology - 23.11.2022
Precision medicine trial opens for rare adult and paedatric cancers
Cancer Research UK, The University of Manchester and Roche Products Ltd ('Roche'), today (Wednesday 23rd), announce that they have opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options.

Health - Pharmacology - 23.11.2022
New approach could push limits of immunotherapy for difficult-to-treat cancers
New approach could push limits of immunotherapy for difficult-to-treat cancers
Cancerous tumors that aren't candidates for surgery or chemotherapy sometimes respond well to alternatives like immunotherapy, but even cutting-edge cancer treatments that harness the immune system have their limits. A recent study by researchers at the University of Wisconsin-Madison points toward a potential new approach for pushing the limits of immunotherapy, opening a door to more effective treatment of inoperable tumors and metastatic cancer.

Life Sciences - Pharmacology - 22.11.2022
Sequencing project to unleash the biotechnology potential of single-celled algae
Sequencing project to unleash the biotechnology potential of single-celled algae
An ambitious plan to sequence the genomes of all known species of euglenoids over the next decade has been launched today.

Health - Pharmacology - 21.11.2022
Researchers win PM's science prizes
Researchers win PM’s science prizes
Two leading researchers from The Australian National University (ANU) who are battling catastrophic climate change and killer infectious diseases are winners in the 2022 Prime Minister's Prizes for Science.

Health - Pharmacology - 21.11.2022
Together against Antibiotic Resistance
Together against Antibiotic Resistance
Antibiotics are major weapons in the fight against bacterial infections. However, antibiotics are increasingly losing efficacy due to the emergence of antibiotic resistance.

Pharmacology - 21.11.2022
Quantity and Quality
Survivors of colon cancer often have symptoms associated with the cancer or treatment for years after treatment, such as fatigue and tingling in fingers and feet. This has a great impact on the perceived quality of life. Whereas current lifestyle advice is mainly aimed at prevention of (colon) cancer, Marlou-Floor Kenkhuis studied in her PhD the relationship between lifestyle with quality of life and fatigue in colon cancer survivors.

Health - Pharmacology - 10.11.2022
Recruitment milestone reached in breast cancer trial
Recruitment milestone reached in breast cancer trial
A milestone 3,000 participants have been recruited to a clinical trial led by UCL and UCLH, which is aimed at reducing the number of patients with breast cancer who receive unnecessary chemotherapy.

Health - Pharmacology - 09.11.2022
Temporary mild damage to heart muscle cells after Covid-19 booster vaccination
Temporary mild damage to heart muscle cells after Covid-19 booster vaccination
An interdisciplinary research team from the University of Basel and the University Hospital Basel has studied the effects of the Covid-19 booster vaccination on the heart muscle.

Health - Pharmacology - 27.10.2022
Overcoming resistance to colon cancer treatment
Overcoming resistance to colon cancer treatment
A team from the UNIGE has found an alternative for patients who have developed resistance to chemotherapy treatments. Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs.

Pharmacology - Economics / Business - 14.10.2022
Documents highlight role of pharmacies in driving opioid epidemic
Documents highlight role of pharmacies in driving opioid epidemic
The latest documents added to the Opioid Industry Documents Archive illustrate the repeated failure of retail pharmacies to heed warning signs and safety guidelines Johns Hopkins University and the U

Health - Pharmacology - 06.10.2022
Why and when to get a bivalent booster
Why and when to get a bivalent booster
The newly available COVID-19 boosters offer the best protection against current strains. But who needs a booster and when should they get it?

Health - Pharmacology - 06.10.2022
How to protect yourself and your family this flu season
How to protect yourself and your family this flu season
Science, Health & Technology Lou Corpuz-Bosshart Adrian Ziemczonek estimates he's put more than 500 needles into arms as a pharmacist who has provided immunizations to people in the community since 2015. As a clinical pharmacist and lecturer at UBC's Pharmacists Clinic , he plays a key role in organizing public vaccination clinics at UBC while also maintaining an active patient care practice based at the Pharmacists Clinic.

Health - Pharmacology - 20.09.2022
Experts create tool to help doctors avoid prescribing drugs to treat other drugs’ side effects
Medications are effective and powerful treatment options for protecting and advancing human health - but, if taken incorrectly, they can also cause harm, particularly among older adults who are taking multiple medications over long periods of time.

Health - Pharmacology - 06.09.2022
MedUni Vienna coordinating EU project to optimise the use of antirheumatic drugs
MedUni Vienna is coordinating an international research project to optimise the use of disease modifying antirheumatic drugs (DMARDs) for treating rheumatoid arthritis. The SQUEEZE project (Maximising Impact of Prescription Drugs in Rheumatoid Arthritis), with total funding of €10.2 million from the EU Framework Programme for Research and Innovation, includes 13 European consortium partners.

Health - Pharmacology - 01.09.2022
What you need to know about bivalent boosters for COVID-19
What you need to know about bivalent boosters for COVID-19
New booster shots designed to target the omicron variant and its subvariants, and the original strain of SARS-CoV-2, could become available in the U.S. in the coming weeks The SARS-CoV

Health - Pharmacology - 18.08.2022
First in Nation: UC San Diego Health Offers Treatment for Hereditary Amyloidosis
New medication allows for less frequent visits for patients, helping improve quality of life UC San Diego Health is first in the nation to offer a new injectable medication to patients with nerve dam

Health - Pharmacology - 01.08.2022
NHS must learn to love smart IV pumps to avoid drug errors
Hospitals must start using "smart" intravenous (IV) infusion technology to its full potential if they are to prevent dangerous drug errors, University of Manchester researchers have found.

Life Sciences - Pharmacology - 22.07.2022
Transport-proteins influence the lung uptake of inhaled drugs
A study by MedUni Vienna's Department of Clinical Pharmacology has identified two transport proteins that can influence the permeability of the lung epithelial barrier for certain drugs.

Health - Pharmacology - 05.07.2022
Pandemic Sciences Institute formally launched in Oxford
The University of Oxford's Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.

Health - Pharmacology - 30.06.2022
’Long COVID’ presents a major health challenge - how can Australia be prepared?
Triple vaccination seems to reduce the chance of long COVID - but we still need to prepare for a jump in cases, write researchers at the University of Sydney.

Pharmacology - Health - 30.06.2022
Documents show McKinsey’s role in fueling opioid crisis
New documents show McKinsey's role in fueling opioid epidemic Consulting firm's work with pharmaceutical companies to help increase sales detailed in UCSF-Johns Hopkins opioid documents archive The O

Health - Pharmacology - 29.06.2022
Q&A: What you should know about new COVID vaccines for young kids
Q&A: What you should know about new COVID vaccines for young kids
Vaccines against COVID-19 are finally available for the youngest Americans. The U.S. Food and Drug Administration voted on June 17 to authorize shots from Moderna and Pfizer for children as young as 6 months.

Health - Pharmacology - 29.06.2022
UCLA survey quantifies COVID-19 vaccine hesitancy among Californians
UCLA survey quantifies COVID-19 vaccine hesitancy among Californians
Despite the U.S. Food and Drug Administration's full approval of the COVID-19 vaccine, 58.8% of Californians who are not fully vaccinated are still worried about its side effects, according to a new UCLA survey.

Health - Pharmacology - 27.06.2022
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
A major clinical trial, led by experts at the University of Nottingham working in partnership with Universities and NHS hospitals including the University of Manchester , has found that by interrupting the treatment of vulnerable people on long-term immune suppressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.

Health - Pharmacology - 27.06.2022
MHH Sarcoma Center successfully DKG-certified
MHH Sarcoma Center successfully DKG-certified
Treatment of rare tumors: In addition to soft tissue tumors, the MHH is the only center in Lower Saxony to be certified for bone sarcomas.

Health - Pharmacology - 27.06.2022
The third wave of COVID-19 delivers the highest mortality risk in Australian ICUs
According to a new study led by Monash University, of those admitted to the ICU with COVID-19, after accounting for age and how sick patients were, the third wave of the disease in Australia was associated with the highest risk of dying in hospital, in comparison with earlier waves. Patients admitted to ICU during the third wave were mostly unvaccinated (75 per cent), younger than the previous two waves (24 per cent > 65 years of age), more likely to be pregnant and/or obese, and less likely to have co-morbid conditions.

Pharmacology - Health - 24.06.2022
Which patients with advanced prostate cancer will benefit from chemotherapy
Researchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chemotherapy is significantly more effective for some men with advanced prostate cancer than others.
1 2 3 4 5 ... 61 Next »